Effects of lactulose on intestinal endotoxin and bacterial translocation in cirrhotic rats

Chinese Medical Journal

Volumn 116, Issue 5, 2003, Pages 767-771

  Zhang, Shuncai ^a   Wang, Wei ^b   Ren, Weiying ^a   Dai, Qian ^a   He, Boming ^a   Zhou, Kang ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Bacterial translocation; Cirrhosis; Endotoxin; Intestinal permeability; Lactulose

Indexed keywords

CHROMIUM 51; ENDOTOXIN; LACTULOSE; PENTETATE TECHNETIUM TC 99M; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL OVERGROWTH; BACTERIAL TRANSLOCATION; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG MECHANISM; INTESTINE FLORA; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; INTESTINE TRANSIT TIME; JEJUNUM; LIVER CIRRHOSIS; MALE; MESENTERY LYMPH NODE; NONHUMAN; RAT; SPLEEN; URINARY EXCRETION;

ANIMALS; BACTERIAL TRANSLOCATION; ENDOTOXINS; GASTROINTESTINAL AGENTS; INTESTINES; LACTULOSE; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0038509991     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Llovet JM, Bartoli R, March F, et al. Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiolgic evidence. J Hepatol 1998; 28: 307-313.
2. Llovet JM, Bartoli R, Planas R, et al. Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock. Hepatology 1996; 23:781-787.
3. Madrid AM, Cumsille F, Defilippi C. Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease. Dig Dis Sci 1997; 42:738-742.
4. Chan CS, Chen GH, Lien HC. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 1998; 28:1187-1190.
5. Runyon BA, Borzio M, Young S. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation and survival in an animal model of cirrhosis. Hepatology 1995; 21:1719-1724.
6. Zhang SC, Dai Q, Wang JY. Effect of oral administration of lactulose on intestinal endotoxemia and cytokines in liver diseases. Chin J Hepatology 2000; 8:185.
7. Bjarnason I, Macpherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995; 108:1566-1581.
8. Campillo B, Pernet P, Bories PN, et al. Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur J Gastroenterol Hepatol 1999; 11:755-759.
9. Miller MS, Galligan JJ, Burks TF. Accurate measurement of intestinal transit in the rat. J Pharmacol Methods 1981; 6: 211-217.
10. Reilly JA, Quigley EMM, Forst CF, et al. Small intestinal transit in the portal hypertensive rat. Gastroenterology 1991; 100:670-674.
11. Guarner C, Soriano G. Spontaneous bacterial peritonitis. Semin Liver Dis 1997; 17:203-217.
12. Guarner C, Runyon BA, Young S, et al. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997; 26:1372-1378.
13. Pardo A, Bartoli R, Zuniga LV, et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 2000; 31:858-863.
14. Cirera I, Bauer TM, Navasa M, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001; 34:32-37.
15. Wang SS, Lee FY, Chan CC. Sequential changes in plasma cytokine and endotoxin levels in cirrhotic patients with bacterial infection. Clin Sci 2000; 98:419-425.
16. Huchzermeyer H, Schumann C. Lactulose-a multifaceted substance. Z Gastroenterol 1997; 35:945-955.
17. Watanabe A, Sakai T, Sato S. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology 1997; 26:1410-1414.
18. Clausen MR, Mortensen PB. Lactulose, disaccharides and colonic flora. Clinical consequences. Drugs 1997; 53:930-942.